Nurse Practitioner · Boston, MA
NPI
1710966924
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
44 Binney St, SW 540
Boston, MA, 02115
Phone (617) 632-5204
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.5M
521 prescriptions
Company payments, 2023
$900
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen Polson prescribed most often to Medicare patients was Imatinib Mesylate, with 85 prescriptions and refills. In total Kathleen Polson wrote 521 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Imatinib Mesylate Generic | 85 | 103 | 22 | $228K |
| Sunitinib Malate Generic | 36 | 36 | Under 11 | $195K |
| Dexamethasone Generic | 25 | 28 | 16 | $220 |
| Eliquis Apixaban | 24 | 30 | Under 11 | $17K |
| Ondansetron Hcl Generic | 19 | 19 | 13 | $109 |
| Lorazepam Generic | 18 | 18 | Under 11 | $90.69 |
| Xarelto Rivaroxaban | 16 | 16 | Under 11 | $8,734 |
| Trazodone Hcl Generic | 14 | 14 | Under 11 | $73.35 |
| Qinlock Ripretinib | 14 | 14 | Under 11 | $671K |
| Meloxicam Generic | 13 | 13 | Under 11 | $7.8 |
| Gleevec Imatinib Mesylate | 12 | 14 | Under 11 | $101K |
| Lisinopril Generic | 12 | 14 | Under 11 | $47.56 |
| Furosemide Generic | 12 | 22 | Under 11 | $28.78 |
Brand drugs: - claims; generic drugs: 422 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Kathleen Polson $900 ($900 in general payments such as food, travel and fees) from 1 company. The largest payer was Deciphera Pharmaceuticals Inc. with $900.
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 1 | $900 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.